Functional mitral insufficiency poses a challenge with regard to the optimal time of intervention, particularly because they are frequently associated with left ventricular (LV) dilation and reduced LV ejection fraction (EF). The registry will document the underlying pathology by using transthoracal echo cardiography (TTE) with analysis of common tenting parameters. OP strategies, data and outcomes will be documented, as well as follow-up data for echocardiography, quality of life and MACCE outcomes after 6 months, 1 and 2 years.
Prospective enrolment of all patients with mitral valve insufficiency and restricted movement of leaflets during systole into a multicentric registry. Exact analysis of the underlying pathology using TTE with analysis of tenting parameters. In patients without contraindications, functional preoperative MRT to determine the functional reserve of ventricular function. Documentation of the quality of life of the patients using the SF12 questionnaire before and after intervention. Documentation of follow-up data (SF12, TTE, NT-pro BNP) at 6 months, 1 and 2 years. Development of operative strategies to improve long-term outcomes in patients with severe LV dilation (typically accompanied by function mitral insufficiency type IIIb).
Study Type
OBSERVATIONAL
Enrollment
105
operative reconstruction
Herzzentrum Leipzig
Leipzig, Saxony, Germany
Zentralklinik Bad Berka
Bad Berka, Germany
Charité - Klinik für kardiovaskuläre Chirurgie
Berlin, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Klinik und Poliklinik für Herz- und Gefäßchirurgie am UHZ am UKE
Hamburg, Germany
Deutsches Herzzentrum München
München, Germany
recurrent mitral valve insufficiency > grade 2
see above
Time frame: 2 years
MACCE
major adverse cardiovascular and cerebrovascular events
Time frame: 1 year
re-intervention at mitral valve
see above
Time frame: 2 years
device therapy (e. g. left ventricular auxiliary device or heart transplant) due to progressive heart failure
see above
Time frame: 2 years
cardiovascular mortality
see above
Time frame: 2 years
re-hospitalisation due to heart failure
see above
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.